Richard Leigh-Pemberton, M.D.
Alkermes, Inc.
2
0
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Mark Sostek, MD
Astrazeneca Wilmington, US
Shared therapeutic areas:
Mark Sostek
AstraZeneca
Shared therapeutic areas:
Karin S Coyne, PHD, MPH
United BioSource
Shared therapeutic areas:
AstraZeneca Scientific Leadership
AstraZeneca
Shared therapeutic areas:
Bruce Berger, MD
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Shared therapeutic areas:
Beth Nordstrom
Evidera
Shared therapeutic areas:
Lia van Zuylen, Prof.dr.
Amsterdam UMC, location VUmc
Shared therapeutic areas:
Andrew N Davies, MD
Consultant Palliative Medicine
Shared therapeutic areas:
Andrew Davies, MD
Royal Surrey County Hospital NHS Foundation Trust
Shared therapeutic areas:
Lindsey Mathew
Bausch Health Companies
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)
ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)
All 2 trials loaded